Mounjaro (Tirzepatide) Instructions for Use
Mounjaro (Tirzepatide) Indications: Diabetes & Weight Loss Instructions for Use
Vtama (tapinarof) 1% Topical Cream (60 gram)
Vtama (tapinarof) 1% Topical Cream for the Treatment of Plaque Psoriasis is Available
Priorix becomes an additional source of measles, mumps and rubella vaccine for US patients
GSK announces US FDA approval of Priorix for the prevention of measles, mumps and rubella in individuals 12 months of age and older GSK plc (LSE/NYSE: GSK) today announced that…
FDA Approves Igalmi (Dexmedetomidine) Sublingual Film
Drug Info: ApoThera Drug Disease Clinical Support App - Assess vital signs including orthostatic measurements before administering Mild or Moderate Schizophrenia Agitation - 120 mcg SL or BUC x 1 dose…
FDA Pulls Authorization for GSK-Vir’s COVID Therapy, Sotrovimab, as BA.2 Cases Rise
The U.S. health regulator said on Tuesday GlaxoSmithKline (GSK.L) and Vir Biotechnology's (VIR.O) antibody therapy was no longer authorized as a COVID-19 treatment, with data suggesting it was unlikely to…
Monoclonal Antibodies for Treating Severe Asthma
Drug Info: ApoThera Drug Disease Clinical Support App ApoThera Specialty Medications, Monoclonal Antibodies, Available for Treating Severe Asthma: - Cinqair (Reslizumab) - Dupixent (Dupilumab) - Fasenra (Benralizumab) - Tezspire (Tezepelumab)…
COVID-19 PCR Test, COVID-19 Antigen Test and COVID-19 Antibody Test
Drug Info: ApoThera Drug Disease Clinical Support App
Tezspire (Tezepelumab), Monoclonal Antibody for the Treatment of Severe Asthma
Drug Info: ApoThera Drug Disease Clinical Support App Severe Asthma - 210 mg SC every 4 weeks - Add-on maintenance treatment of severe asthma Missed Dose - Administer dose as…
Opdualag (Nivolumab-Relatlimab), for the Treatment of Melanoma
Drug Info: ApoThera Drug Disease Clinical Support App Melanoma Unresectable or Metastatic - 480mg/160mg IV every 4 weeks - Continue until disease progression or unacceptable toxicity occurs Infusion-related Reactions Grade…
Rinvoq (upadacitinib) New Indications: Treatment of Moderate-to-Severe Ulcerative Colitis (UC)
Drug Info: ApoThera Drug Disease Clinical Support App Rinvoq (upadacitinib) receives FDA approval for the treatment of adults with moderately to severely active Ulcerative Colitis (UC) Induction Dose - 45…